SMi Source lesson Anticoagulation: Standard Anticoagulants has the following microlearning topics
1. Introduction
2. Anticoagulation Therapy Indications
3. Atrial Fibrillation (AF): Stroke Risk
4. Atrial Fibrillation (AF): Guidelines for Anticoagulation Therapy
5. Venous Thromboembolism (VTE): Treatment Guideline Overview
6. Venous Thromboembolism (VTE): Uncomplicated Treatment
7. Complicated Venous Thromboembolism (VTE) Treatment
8. Venous Thromboembolism (VTE)
9. Venous Thromboembolism (VTE) Treatment Follow-Up and Secondary Prevention: Bridging and Perioperative Management
10. Standard Anticoagulants
11. Vitamin K Antagonists (VKAs)
12. Unfractionated Heparin (UFH)
13. Low Molecular Weight Heparin (LMWH)
14. Low Molecular Weight Heparin (LMWH): Indications
15. Fondaparinux
16. Aspirin
17. Selected Clinical Studies
18. Vitamin K Antagonists (VKAs): Warfarin
19. Vitamin K Antagonists (VKAs): Warfarin
20. Unfractionated Heparin (UFH) and Low Molecular Weight Heparins (LMWHs)
21. Fondaparinux: Treatment of Deep Vein Thrombosis
22. Fondaparinux: Treatment of Pulmonary Embolism
23. Aspirin: Stroke Prevention in Atrial Fibrillation (AF)
24. Therapeutic Challenges of Antithrombotic Treatment
25. Vitamin K Antagonists (VKAs): Warfarin
26. Warfarin: Monitoring and Anticoagulant Reversal
27. Unfractionated Heparin (UFH)
28. Low Molecular Weight Heparin (LMWH): Boxed Warning
29. Low Molecular Weight Heparin (LMWH): Enoxaparin and Dalteparin
30. Fondaparinux: Boxed Warning, Laboratory Monitoring, and Anticoagulant Reversal
31. Aspirin: Warnings and Anticoagulant Reversal
32. Table of Agents
